作者：
Xue,Wang [1]
;
Junnan,Liu [2]
;
Anca,Azoitei [1]
;
Tim,Eiseler [3]
;
Sabine,Meessen [1]
;
Wencheng,Jiang [4]
;
Xi,Zheng [1]
;
Arika W,Makori [5]
;
Markus,Eckstein [1]
;
Arndt,Hartmann [1]
;
Stephan,Stilgenbauer [6]
;
Mohamed,Elati [7]
;
Meike,Hohwieler [1]
;
Alexander,Kleger [8]
;
Axel,John [8]
;
Friedemann,Zengerling [9]
;
Felix,Wezel [10]
;
Christian,Bolenz [11]
;
Cagatay,Günes [11]
作者单位：
Department of Urology, Ulm University Hospital, Helmholtzstr. 10, 89081, Ulm, Germany.
[1]
Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
[2]
Department of Urology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
[3]
Department of Internal Medicine I, University Hospital, Ulm, Germany.
[4]
Division of Hepatology, Department of Medicine II, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany.
[5]
Department of Urology, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, 210008, Jiangsu, China.
[6]
Institute of Urology, Nanjing University, Nanjing, 210008, Jiangsu, China.
[7]
Institute of Pathology, Friedrich-Alexander University, Erlangen, Germany.
[8]
Department of Internal Medicine III, University Hospital, Ulm, Germany.
[9]
CANTHER, ONCOLille Institute, University of Lille, CNRS UMR 1277, Inserm U9020, 59045, Lille Cedex, France.
[10]
Institute of Mol. Oncology and Stem Cell Biology, University Hospital, Ulm, Germany.
[11]
Department of Urology, Ulm University Hospital, Helmholtzstr. 10, 89081, Ulm, Germany. Cagatay.guenes@uniklinik-ulm.de.
[12]
DOI
10.1007/s00018-023-04959-6
PMID
37740130
发布时间
2023-10-13
换一批
换一批
